Zmiana równowagi TH1/TH2 w szczepionkach typu split przeciwko grypie zawierających adjuwant

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

O'HAGAN, DEREK

申请号：

PL06808431

公开号：

PL1951300T3

申请日:

2006.11.06

申请国别(地区):

PL

年份:

2012

代理人:

摘要：

The invention seeks to avoid components in split vaccines that could cause an excessive Th2 response. Thus the invention provides an immunogenic composition comprising a split influenza virus antigen and a Th1 adjuvant, wherein the antigen is preferably prepared from a virus grown in cell culture (e.g., it is free from egg proteins).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/